For example, isocitrate dehydrogenase 1 (IDH1) mutations in gliomas inhibit interferon regulatory factor 3/7 (IRF3/7) expression, thereby attenuating type I interferon responses [174,175]. This evidence concerns the gene IRF3 and central nervous system cancer.